BridgeBio Pharma Cash from Financing (Quarterly) Insights

BridgeBio Pharma Inc (BBIO)

30.10 -0.94 (-3.04%) USD | NASDAQ | May 17, 16:00

30.10 0.00 (0.00%) Pre-Market: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	279.55M
December 31, 2023	-4.523M
September 30, 2023	307.04M
June 30, 2023	-1.231M
March 31, 2023	150.25M
December 31, 2022	6.377M
September 30, 2022	1.445M
June 30, 2022	-20.80M
March 31, 2022	-0.16M
December 31, 2021	325.38M
September 30, 2021	-135.46M
June 30, 2021	-1.391M
March 31, 2021	547.91M

Date	Value
December 31, 2020	4.531M
September 30, 2020	2.782M
June 30, 2020	0.703M
March 31, 2020	439.17M
December 31, 2019	42.90M
September 30, 2019	367.51M
June 30, 2019	-9.969M
March 31, 2019	-1.651M
December 31, 2018	274.17M
September 30, 2018	-1.727M
June 30, 2018	213.41M
March 31, 2018	15.69M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-135.46M

Minimum

Sep 2021

547.91M

Maximum

Mar 2021

115.10M

Average

3.656M

Median

Cash from Financing (Quarterly) Benchmarks

Pfizer Inc	-4.931B
Alnylam Pharmaceuticals Inc	28.91M
Regenxbio Inc	120.72M
ACADIA Pharmaceuticals Inc	1.043M
Biomarin Pharmaceutical Inc	-42.79M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-219.54M
Cash from Investing (Quarterly)	22.75M
Free Cash Flow	-605.72M
Free Cash Flow Per Share (Quarterly)	-1.237
Free Cash Flow to Equity (Quarterly)	-210.23M
Free Cash Flow Yield	-11.89%